There are 11 resources available
Optimal selection of patients with untreated advanced renal carcinoma for combination and monotherapy regimens: Agents, combinations and emerging biomarkers
Presenter: Jens Bedke
Session: ESMO Colloquium supported by Eisai Europe Ltd - How to optimise efficacy and safety of targeted agent/IO management strategies in advanced solid tumours: Single agents, combinations and biomarkers
Resources:
Slides
Webcast
Optimal selection of patients with untreated advanced hepatocellular cancer for combination and monotherapy regimens: Agents, combinations and emerging biomarkers
Presenter: Masafumi Ikeda
Session: ESMO Colloquium supported by Eisai Europe Ltd - How to optimise efficacy and safety of targeted agent/IO management strategies in advanced solid tumours: Single agents, combinations and biomarkers
Resources:
Slides
Webcast
Optimal selection of patients with platinum-pretreated advanced endometrial carcinoma for combination and monotherapy regimens: Agents, combinations and emerging biomarkers
Presenter: Cristiana Sessa
Session: ESMO Colloquium supported by Eisai Europe Ltd - How to optimise efficacy and safety of targeted agent/IO management strategies in advanced solid tumours: Single agents, combinations and biomarkers
Resources:
Slides
Webcast
Proactive and reactive strategies for improving patient compliance and safety of VEGFR-TKI/immune checkpoint inhibitor combinations
Presenter: Giuseppe Procopio
Session: ESMO Colloquium supported by Eisai Europe Ltd - How to optimise efficacy and safety of targeted agent/IO management strategies in advanced solid tumours: Single agents, combinations and biomarkers
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Jens Bedke
Session: ESMO Colloquium supported by Eisai Europe Ltd - How to optimise efficacy and safety of targeted agent/IO management strategies in advanced solid tumours: Single agents, combinations and biomarkers
Resources:
Slides
Webcast
A clinical case of a female patient with advanced RET-fused non-small cell lung adenocarcinoma: MRD, disease monitoring, secondary resistance
Presenter: Maria Gabriela Oliveira Fernandes
Session: ESMO Colloquium co-supported by Thermo Fisher Scientific and Eli Lilly - Multiplex biomarker profiling in contemporary oncology: From testing to understanding and impacting
Resources:
Webcast
Technologies for multiplex molecular testing and ESMO recommendations for practice and research application in solid tumours
Presenter: Albrecht Stenzinger
Session: ESMO Colloquium co-supported by Thermo Fisher Scientific and Eli Lilly - Multiplex biomarker profiling in contemporary oncology: From testing to understanding and impacting
Resources:
Webcast
Molecular tumour boards and application in oncology networks: Challenges and opportunities on the road towards optimizing patient benefit
Presenter: Rodrigo Dienstmann
Session: ESMO Colloquium co-supported by Thermo Fisher Scientific and Eli Lilly - Multiplex biomarker profiling in contemporary oncology: From testing to understanding and impacting
Resources:
Webcast
Availability, turnaround times and report interpretation: Implementation barriers and knowledge gaps related to tumour molecular profiling in practice
Presenter: Emiliano Calvo
Session: ESMO Colloquium co-supported by Thermo Fisher Scientific and Eli Lilly - Multiplex biomarker profiling in contemporary oncology: From testing to understanding and impacting
Resources:
Webcast
Live conclusions
Presenter: Emiliano Calvo
Session: ESMO Colloquium co-supported by Thermo Fisher Scientific and Eli Lilly - Multiplex biomarker profiling in contemporary oncology: From testing to understanding and impacting
Resources:
Slides
Webcast